Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSPAN16 antisense RNA 1 (TSPAN16-AS1, also known as HSPC102) is a human long non-coding RNA transcribed from the antisense strand adjacent to the TSPAN16 gene locus. Antisense lncRNAs typically regulate the expression of nearby or overlapping protein-coding genes via a variety of mechanisms, including altering chromatin structure, transcriptional interference, and mRNA stability. While some antisense lncRNAs have been implicated in disease, there is currently no specific evidence for the involvement of TSPAN16-AS1 itself in particular biological pathways or disease processes.
Not applicable; there are no drugs targeting TSPAN16-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TSPAN16 antisense RNA 1 (TSPAN16-AS1).